MAPT and Alzheimer disease: Cognitive decline in the development of Alzheimer’s disease has been associated with progressive brain atrophy and the accumulation of hyperphosphorylated tau and amyloid proteins.1 A functional neuronal network is supported by a fine balance between neuronal excitation and inhibition (E/I) and a disruption in this balance may lead to alterations in network organization.